Primary care pharmacist jobs could be at risk following changes to ARRS funding Under new arrangements for the Additional Roles Reimbursement Scheme, primary care networks will not be able to redistribute unspent funds between each other, which have previously been used for recruitment to address staff shortages.
Copy link to page Download PDF
Primary care networks can claim reimbursement for 17 healthcare roles, including pharmacists and pharmacy technicians, under the scheme Stephen Barnes/Medical / Alamy Stock Photo
Pharmacists working for primary care networks (PCNs) could face redundancies following changes to the Additional Roles Reimbursement Scheme (ARRS) in 2024/2025, it has been warned.
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Last updated 23 May 2024 16:20